Walter S.  Woltosz net worth and biography

Walter Woltosz Biography and Net Worth

Director of Simulations Plus
The professional career of Walter S. (Walt) Woltosz testifies to the potential of an engineering mind to impact the world. Combining his engineering knowledge with a problem-solving approach, Woltosz has established himself as an engineer who has improved the quality of life for people worldwide. His commitment to Auburn Engineering, and his recognition of the value of graduate education, led him to make a generous gift to the college’s graduate fellowship program. In recognition of his support, students who hold graduate fellowships within the college are known as Woltosz Fellows.

Woltosz holds bachelor’s and master’s degrees from Auburn University in aerospace engineering, 1969 and 1977, and a master’s in administrative science from the University of Alabama in Huntsville. He worked as an electronics engineer with the Federal Aviation Administration and later with Northrop Services developing simulation/optimization computer programming for the space shuttle ascent trajectory. During his 13-year career in the aerospace industry, Woltosz pioneered and managed the development of software for the simulation and optimization of a wide range of solid propellant rocket motors and missile systems, including the space shuttle, Advanced Medium Range Air-to-Air Missile (AMRAAM), Midgetman small intercontinental ballistic missile, and the Pegasus air-launched satellite booster.

In 1981, he established Words+, Inc., a company that designs, manufactures and sells computer-based communication systems. He is internationally known for being the first person to create an integrated communications system based on a personal computer, and his work in this area radically transformed the way in which people with disabilities communicate. In 1986, Woltosz and his team developed the first system with adaptive word prediction and developed the comprehensive ACES (Augmentative Communication Evaluation System) – the largest software development project undertaken in the field. His innovative communication systems have been used by people with disabilities throughout the world, including author Sir Stephen Hawking, the world-renowned astrophysicist who has suffered from Amyotrophic Lateral Sclerosis (ALS) for decades.

Having developed an array of innovations for the augmentative communication field, Woltosz turned his attention to a broader scope, and in 1996, he created Simulations Plus, Inc., a leader in groundbreaking drug discovery and simulation software for conducting drug research. Simulations Plus is a major developer of absorption, distribution, metabolism and excretion (ADME) neural net and simulation software for the pharmaceutical and biotechnology industries. The company’s software allows pharmaceutical scientists to predict certain key potential drug dynamics, helping reduce multi-million dollar clinical trial failures and speeding up the time to market of effective new medications.

Woltosz holds the Distinguished Auburn Engineer Award and is a member of the State of Alabama Engineering Hall of Fame. He is a member of the Auburn Alumni Engineering Council, the Engineering Keystone Society, the Engineering Eagles Society, and the Engineering Ginn Society, as well as the 1856 Society and the All American Society. In addition to his support of the graduate fellowship program, he has provided funding for several endowed professorships and supports the college’s Formula and Baja SAE student competition teams.

What is Walter S. Woltosz's net worth?

The estimated net worth of Walter S. Woltosz is at least $162.58 million as of April 1st, 2024. Mr. Woltosz owns 3,600,195 shares of Simulations Plus stock worth more than $162,584,806 as of April 20th. This net worth approximation does not reflect any other assets that Mr. Woltosz may own. Additionally, Mr. Woltosz receives an annual salary of $80,000.00 as Director at Simulations Plus. Learn More about Walter S. Woltosz's net worth.

How old is Walter S. Woltosz?

Mr. Woltosz is currently 79 years old. There are 5 older executives and no younger executives at Simulations Plus. Learn More on Walter S. Woltosz's age.

What is Walter S. Woltosz's salary?

As the Director of Simulations Plus, Inc., Mr. Woltosz earns $80,000.00 per year. There are 5 executives that earn more than Mr. Woltosz. The highest earning executive at Simulations Plus is Mr. Shawn M. O'Connor, Chief Executive Officer, who commands a salary of $847,560.00 per year. Learn More on Walter S. Woltosz's salary.

How do I contact Walter S. Woltosz?

The corporate mailing address for Mr. Woltosz and other Simulations Plus executives is 42505 10TH STREET WEST, LANCASTER CA, 93534. Simulations Plus can also be reached via phone at (661) 723-7723 and via email at [email protected]. Learn More on Walter S. Woltosz's contact information.

Has Walter S. Woltosz been buying or selling shares of Simulations Plus?

Over the course of the past ninety days, Walter S. Woltosz has sold $798,800.00 in shares of Simulations Plus stock. Most recently, Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction on Monday, April 1st. The shares were sold at an average price of $39.94, for a transaction totalling $798,800.00. Following the completion of the sale, the director now directly owns 3,600,195 shares of the company's stock, valued at $143,791,788.30. Learn More on Walter S. Woltosz's trading history.

Who are Simulations Plus' active insiders?

Simulations Plus' insider roster includes John Paglia (Director), and Walter Woltosz (Director). Learn More on Simulations Plus' active insiders.

Are insiders buying or selling shares of Simulations Plus?

In the last year, insiders at the technology company sold shares 13 times. They sold a total of 177,744 shares worth more than $7,339,016.30. The most recent insider tranaction occured on April, 1st when Director Walter S Woltosz sold 20,000 shares worth more than $798,800.00. Insiders at Simulations Plus own 20.9% of the company. Learn More about insider trades at Simulations Plus.

Information on this page was last updated on 4/1/2024.

Walter S. Woltosz Insider Trading History at Simulations Plus

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/1/2024Sell20,000$39.94$798,800.003,600,195View SEC Filing Icon  
2/1/2024Sell18,945$38.02$720,288.903,641,250View SEC Filing Icon  
1/2/2024Sell20,000$44.46$889,200.003,659,403View SEC Filing Icon  
12/4/2023Sell21,802$38.67$843,083.343,771,453View SEC Filing Icon  
12/1/2023Sell31,148$38.80$1,208,542.403,793,255View SEC Filing Icon  
6/28/2023Sell16,246$43.07$699,715.223,840,212View SEC Filing Icon  
5/30/2023Sell20,000$46.05$921,000.003,856,458View SEC Filing Icon  
4/26/2023Sell20,000$41.52$830,400.003,875,739View SEC Filing Icon  
3/29/2023Sell20,000$42.81$856,200.003,895,739View SEC Filing Icon  
2/24/2023Sell20,000$38.04$760,800.003,915,739View SEC Filing Icon  
1/30/2023Sell2,258$39.74$89,732.923,935,010View SEC Filing Icon  
1/27/2023Sell17,742$39.70$704,357.403,937,268View SEC Filing Icon  
12/28/2022Sell20,000$36.15$723,000.003,955,010View SEC Filing Icon  
11/28/2022Sell20,000$39.89$797,800.004,070,010View SEC Filing Icon  
10/27/2022Sell20,000$41.64$832,800.004,089,307View SEC Filing Icon  
9/28/2022Sell20,000$49.55$991,000.004,077,907View SEC Filing Icon  
8/29/2022Sell18,121$61.49$1,114,260.294,099,786View SEC Filing Icon  
7/27/2022Sell20,000$61.19$1,223,800.004,117,634View SEC Filing Icon  
6/28/2022Sell17,461$48.00$838,128.004,140,173View SEC Filing Icon  
5/27/2022Sell20,000$47.99$959,800.004,157,634View SEC Filing Icon  
4/27/2022Sell13,288$46.68$620,283.844,183,971View SEC Filing Icon  
3/29/2022Sell15,140$48.55$735,047.00View SEC Filing Icon  
2/24/2022Sell14,333$37.67$539,924.11View SEC Filing Icon  
1/27/2022Sell20,000$39.32$786,400.00View SEC Filing Icon  
11/29/2021Sell7,668$47.56$364,690.08View SEC Filing Icon  
11/26/2021Sell12,332$48.93$603,404.76View SEC Filing Icon  
10/27/2021Sell20,000$45.32$906,400.00View SEC Filing Icon  
9/28/2021Sell20,000$38.54$770,800.00View SEC Filing Icon  
8/30/2021Sell8,803$44.90$395,254.70View SEC Filing Icon  
8/27/2021Sell9,700$44.67$433,299.004,430,831View SEC Filing Icon  
7/29/2021Sell12,455$47.09$586,505.954,443,657View SEC Filing Icon  
6/24/2021Sell10,698$53.60$573,412.804,471,512View SEC Filing Icon  
5/24/2021Sell13,825$52.18$721,388.504,494,071View SEC Filing Icon  
4/26/2021Sell24,000$68.54$1,644,960.004,519,478View SEC Filing Icon  
3/25/2021Sell24,000$60.04$1,440,960.00
2/22/2021Sell24,000$73.01$1,752,240.00
1/25/2021Sell24,000$76.43$1,834,320.004,575,614View SEC Filing Icon  
12/23/2020Sell24,000$72.71$1,745,040.004,659,614View SEC Filing Icon  
10/27/2020Sell24,000$68.95$1,654,800.004,707,359View SEC Filing Icon  
9/24/2020Sell24,000$66.08$1,585,920.004,731,359View SEC Filing Icon  
7/27/2020Sell24,000$66.13$1,587,120.004,779,153View SEC Filing Icon  
6/24/2020Sell24,000$55.82$1,339,680.004,803,153View SEC Filing Icon  
5/22/2020Sell24,000$39.35$944,400.004,827,153View SEC Filing Icon  
4/24/2020Sell24,000$41.25$990,000.004,850,772View SEC Filing Icon  
3/25/2020Sell24,000$31.71$761,040.004,874,772View SEC Filing Icon  
2/24/2020Sell24,000$36.69$880,560.004,898,772View SEC Filing Icon  
1/27/2020Sell24,000$33.26$798,240.004,922,327View SEC Filing Icon  
11/22/2019Sell24,000$34.67$832,080.005,040,327View SEC Filing Icon  
10/27/2019Sell24,000$33.45$802,800.005,063,918View SEC Filing Icon  
9/24/2019Sell24,000$35.86$860,640.005,087,918View SEC Filing Icon  
8/26/2019Sell24,000$36.22$869,280.00View SEC Filing Icon  
5/28/2019Sell18,500$25.67$474,895.005,178,083View SEC Filing Icon  
4/26/2019Sell18,500$22.11$409,035.005,196,039View SEC Filing Icon  
3/27/2019Sell18,500$20.64$381,840.005,214,539View SEC Filing Icon  
2/26/2019Sell18,500$20.65$382,025.00View SEC Filing Icon  
1/28/2019Sell18,500$18.66$345,210.005,250,912View SEC Filing Icon  
10/29/2018Sell18,500$20.01$370,185.005,399,408View SEC Filing Icon  
9/27/2018Sell18,500$19.92$368,520.005,417,908View SEC Filing Icon  
8/27/2018Sell18,500$20.33$376,105.005,436,408View SEC Filing Icon  
7/27/2018Sell18,500$17.76$328,560.005,454,908View SEC Filing Icon  
5/29/2018Sell18,500$19.27$356,495.005,454,408View SEC Filing Icon  
4/26/2018Sell18,500$17.20$318,200.005,472,908View SEC Filing Icon  
3/27/2018Sell18,500$14.54$268,990.005,466,408View SEC Filing Icon  
2/27/2018Sell18,500$16.13$298,405.005,482,916View SEC Filing Icon  
12/27/2017Sell18,500$16.25$300,625.005,502,416View SEC Filing Icon  
12/27/2017Sell18,500$16.25$300,625.005,502,416View SEC Filing Icon  
11/29/2017Sell18,500$15.78$291,930.005,610,916View SEC Filing Icon  
10/28/2017Sell18,500$16.37$302,845.005,629,416View SEC Filing Icon  
9/27/2017Sell18,500$15.45$285,825.005,647,916View SEC Filing Icon  
7/27/2017Sell18,500$15.07$278,795.005,684,916View SEC Filing Icon  
5/4/2017Sell24,596$12.52$307,941.925,837,940View SEC Filing Icon  
1/29/2016Sell58,181$11.27$655,699.87View SEC Filing Icon  
See Full Table

Walter S. Woltosz Buying and Selling Activity at Simulations Plus

This chart shows Walter S Woltosz's buying and selling at Simulations Plus by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Simulations Plus Company Overview

Simulations Plus logo
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. The company also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, RENAsym, IPFsym, and MITOsym products. In addition, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, it offers creative and insightful consulting services to support its quantitative systems pharmacology/quantitative systems toxicology modelling. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
Read More

Today's Range

Now: $45.16
Low: $44.26
High: $45.39

50 Day Range

MA: $43.22
Low: $38.46
High: $50.73

2 Week Range

Now: $45.16
Low: $32.69
High: $52.69

Volume

99,072 shs

Average Volume

133,417 shs

Market Capitalization

$902.75 million

P/E Ratio

85.21

Dividend Yield

0.54%

Beta

0.72